Risks of adjuvant whole brain radiation therapy outweigh benefits for patients with limited brain metastases

Dr Jan Buckner - Mayo Clinic, Rochester, USA
Risks of adjuvant whole brain radiation therapy outweigh benefits for patients with limited brain metastases ( Dr Jan Buckner - Mayo Clinic, Rochester, USA )
31 May 2015

Risks of adjuvant whole brain radiation therapy outweigh benefits for patients with limited brain metastases

Dr Jan Buckner - Mayo Clinic, Rochester, USA
Risks of adjuvant whole brain radiation therapy outweigh benefits for patients with limited brain metastases ( Dr Jan Buckner - Mayo Clinic, Rochester, USA )
31 May 2015

How will genomics be applied to patient therapy in future?

Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas
How will genomics be applied to patient therapy in future? ( Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas )
30 Apr 2015

New approaches and new partnership models for biomarker based clinical research

Dr Denis Lacombe, EORTC, Brussels, Belgium
New approaches and new partnership models for biomarker based clinical research ( Dr Denis Lacombe, EORTC, Brussels, Belgium )
6 Jan 2015

Aims and successes of the 2nd EurocanPlatform project translational research course

Christina von Gertten, Karolinska Institutet, Stockholm, Sweden
Aims and successes of the 2nd EurocanPlatform project translational research course ( Christina von Gertten, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015

Epigenome deregulation in cancer

Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France
Epigenome deregulation in cancer ( Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France )
6 Jan 2015

Immunotherapy of cancer: recent progress and future challenges

Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden
Immunotherapy of cancer: recent progress and future challenges ( Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015

Reasons to attend the EurocanPlatform translational research course 2015

Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany
Reasons to attend the EurocanPlatform translational research course 2015 ( Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany )
6 Jan 2015

2nd EurocanPlatform translational research course is good for networking

Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal
2nd EurocanPlatform translational research course is good for networking ( Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal )
6 Jan 2015

The p-medicine project and personalised medicine

Prof Norbert Graf, Saarland University, Homburg, Germany
The p-medicine project and personalised medicine ( Prof Norbert Graf, Saarland University, Homburg, Germany )
6 Jan 2015

Biobanking biological materials and linkage to clinical information

Dr Peter Riegman, Erasmus Medical Center, Rotterdam, The Netherlands
Biobanking biological materials and linkage to clinical information ( Dr Peter Riegman, Erasmus Medical Center, Rotterdam, The Netherlands )
6 Jan 2015

The role of health economics in cancer outcomes research

Prof Bengt Jönsson, Stockholm School of Economics, Stockholm, Sweden
The role of health economics in cancer outcomes research ( Prof Bengt Jönsson, Stockholm School of Economics, Stockholm, Sweden )
6 Jan 2015